Conference Details - Agenda
View all Conferences
Continuing Education Information
Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity is approved for AMA PRA Category 1 Credit™
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Ninth International Congress on Genitourinary Malignancies
Renaissance Mayflower Hotel
Washington, DC
July 16-18, 2009
| 12:00 pm |
Registration
|
| 1:00 pm |
Welcome and Introductions
|
| 1:05 pm |
Presession Survey
|
| 1:10 pm |
PIN: What Is It, and How Do We Treat It?
Samir Taneja |
| 1:30 pm |
Natural History of Prostate Cancer
Stephen Freedland |
| 1:50 pm |
Prostate Imaging
Clare M.C. Tempany |
| 2:10 pm |
Preventing Prostate Cancer: 2009 Update
Eric Klein |
| 2:30 pm |
Balanced Views on Surveillance
Laurence Klotz |
| 2:50 pm |
Break
|
| 3:05 pm |
Current Management of Node-Positive (D1) Disease
Howard Sandler |
| 3:25 pm |
Timing of Androgen Deprivation Therapy
William K. Oh |
| 3:45 pm |
Salvage Radiation
Alan Pollack |
| 4:05 pm |
After Taxanes Fail: Where To Now?
Daniel P. Petrylak |
| 4:35 pm |
Panel Discussion
|
| 4:55 pm |
Postsession Survey
|
| 5:00 pm |
Adjourn
|
| 7:30 am |
Registration and Continental Breakfast
|
| 8:00 am |
Welcome and Introductions
|
| 8:05 am |
Presession Survey
|
| 8:10 am |
Germline Genetics in Prostate Cancer
Eric Klein |
| 8:25 am |
Question-and-Answer Session
|
| 8:30 am |
Somatic Genetics in Prostate Cancer
Angelo DeMarzo |
| 8:45 am |
Question-and-Answer Session
|
| 8:50 am |
Prostate Cancer Pathogenesis and Molecular Heterogeneity
Edward Gelmann |
| 9:05 am |
Question-and-Answer Session
|
| 9:10 am |
Novel Prostate Cancer Markers
Robert H. Getzenberg |
| 9:25 am |
Question-and-Answer Session
|
| 9:30 am |
Postsession Survey
|
| 9:35 am |
Break
|
| 9:50 am |
Complications of Androgen Deprivation Therapy
William K. Oh |
| 10:10 am |
Sexual Rehabilitation
Wayne Hellstrom |
| 10:30 am |
Testosterone Replacement in Patients With Prostate Cancer
Abraham Morgentaler |
| 10:50 am |
Panel Discussion and Perspectives
|
| 11:15 am |
Lunch
|
| 12:20 pm |
PCA3: Ready for Prime Time?
David G. McLeod |
| 12:40 pm |
Surgical Advances in Prostate Cancer
James Eastham |
| 1:00 pm |
Measurement of Circulating Tumor Cells
Robert L. Vessella |
| 1:20 pm |
Immunologic Approaches to Therapy
Susan Slovin |
| 1:40 pm |
Novel Therapies: 2009 Update
Oliver Sartor |
| 2:00 pm |
Panel Discussion and Perspectives
|
| 2:20 pm |
Break
|
| 2:35 pm |
Presession Survey
|
| 2:40 pm |
Surgical Management of Early Disease
Colin P. N. Dinney |
| 3:00 pm |
Current Neoadjuvant and Adjuvant Therapies for Bladder Cancer
Jonathan E. Rosenberg |
| 3:20 pm |
Optimal Chemotherapy for Advanced Disease
Derek Raghavan |
| 3:40 pm |
Bladder Cancer: Novel Agents
Dean Bajorin |
| 4:00 pm |
Case-Based Panel Discussion
|
| 4:20 pm |
Postsession Survey
|
| 4:25 pm |
Adjourn
|
| 4:30 pm |
Attendee-Submitted Cases Discussed by Panel of Experts
|
| 6:15 pm |
Adjourn
|
| 7:30 am |
Registration and Continental Breakfast
|
| 8:00 am |
Welcome and Introductions
|
| 8:05 am |
Renal Tumors: Pathologic and Epidemiologic Characteristics
Victor E. Reuter |
| 8:20 am |
Question-and-Answer Session
|
| 8:25 am |
Biology of Resistance
Michael Atkins |
| 8:40 am |
Question-and-Answer Session
|
| 8:45 am |
Biomarkers in RCC: 2009 Update
Daniel George |
| 9:00 am |
Question-and-Answer Session
|
| 9:05 am |
Emerging Molecular Targets in RCC
James Brugarolas |
| 9:20 am |
Question-and-Answer Session
|
| 9:25 am |
Break
|
| 9:40 am |
Presession Survey
|
| 9:45 am |
Treatment-Naive Patients: Favorable/Intermediate Risk
Robert Motzer |
| 10:05 am |
Treatment-Naive Patients: Poor Risk
Ronald Bukowski |
| 10:25 am |
Recurrent/Resistant Disease
Thomas Hutson |
| 10:45 am |
Treating Non–Clear Cell RCC
Walter Stadler |
| 11:05 am |
What Is the Role of Immunotherapy?
David McDermott |
| 11:25 am |
Panel Poll and Discussion
|
| 11:45 am |
Postsession Survey
|
| 11:50 am |
Lunch
|
| 1:00 pm |
Presession Survey
|
| 1:05 pm |
Cardiovascular Toxicity
Jean-Bernard Durand |
| 1:25 pm |
Dermatologic Toxicity
Mario E. Lacouture |
| 1:45 pm |
Endocrine Toxicity
Jorge A. Garcia |
| 2:05 pm |
Managing Fatigue and Asthenia
Mellar Davis |
| 2:25 pm |
Case-Based Panel Discussion and Postsession Survey
|
| 2:45 pm |
Break
|
| 3:00 pm |
Tribute to Dr. Andrew Novick
Robert Uzzo |
| 3:05 pm |
Debate: Surgical or Nonsurgical Intervention for Small Renal Tumors?
|
| 15 min |
Surgical Intervention for Small Renal Tumors
Robert Uzzo |
| 15 min |
Nonsurgical Intervention for Small Renal Tumors
Steven C. Campbell |
| 3:35 pm |
Rebuttals
|
| 3:45 pm |
Cased-Based Discussion: Case vignettes that highlight practical issues in managing small, large/invasive, and metastatic RCC
Moderators: Christopher G. Wood and Steven C. Campbell |
| 4:45 pm |
Closing Comments
|
| 5:00 pm |
Adjourn
|